BioCentury
ARTICLE | Politics & Policy

Oregon governor signs price transparency bill

March 13, 2018 7:20 PM UTC

Oregon Governor Kate Brown signed into law drug price transparency bill H.B. 4005 on Tuesday.

The new law requires manufacturers to report information annually on drug prices and price increases, including factors contributing to the price hikes. Sponsors must also disclose R&D and marketing costs, revenues and profits. The law applies to drugs for which the monthly price exceeds $100 and the price increased more than 10% over the previous calendar year. Initial reports are due in July 2019...